Compare PEN & BEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PEN | BEN |
|---|---|---|
| Founded | 2004 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 14.5B |
| IPO Year | 2015 | 2013 |
| Metric | PEN | BEN |
|---|---|---|
| Price | $330.16 | $23.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 9 |
| Target Price | ★ $357.33 | $25.89 |
| AVG Volume (30 Days) | 563.4K | ★ 4.5M |
| Earning Date | 04-22-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 5.64% |
| EPS Growth | ★ 1155.56 | 7.06 |
| EPS | ★ 4.52 | 0.46 |
| Revenue | $1,403,665,000.00 | ★ $5,774,500,000.00 |
| Revenue This Year | $14.34 | N/A |
| Revenue Next Year | $13.71 | $5.76 |
| P/E Ratio | $73.05 | ★ $50.89 |
| Revenue Growth | ★ 17.50 | N/A |
| 52 Week Low | $221.26 | $16.25 |
| 52 Week High | $362.41 | $28.32 |
| Indicator | PEN | BEN |
|---|---|---|
| Relative Strength Index (RSI) | 37.87 | 39.52 |
| Support Level | $302.19 | $22.68 |
| Resistance Level | $338.99 | $23.65 |
| Average True Range (ATR) | 2.36 | 0.67 |
| MACD | -0.76 | 0.01 |
| Stochastic Oscillator | 30.47 | 34.16 |
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Franklin Resources provides investment services for individual and institutional investors. At the end of July 2025, Franklin had $1.617 trillion in managed assets, composed primarily of equity (41%), fixed-income (27%), multi-asset/balanced (11%) funds, alternatives (16%) and money market funds (5%). Distribution tends to be weighted between retail investors (56% of AUM) and institutional accounts (41%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 31% of its assets under management invested in global/international strategies and just as much sourced from clients domiciled outside the United States.